Table 2

Site of initial recurrence by sentinel lymph node status
Number all patients SLN positive patients SLN negative patients p
SLN status 197 44 (22%) 153 (78%)
Recurrence:
Yes 34 (17%) 14 (32%) 20 (13%) 0.002
No 163 (83%) 30 (68%) 133 (87%)
Site of initial recurrence*:
Local/in transit 17 (50%) 9 (64%) 8 (40%) NS
Regional lymph node 16 (47%) 6 (43%) 10 (50%) NS
Distant metastatic 20 (59%) 8 (57%) 14 (70%) NS

*Some patients may present multiple sites of recurrence.

SLN: sentinel lymph node.

NS: not significant.

Biver-Dalle et al.

Biver-Dalle et al. BMC Dermatology 2012 12:21   doi:10.1186/1471-5945-12-21

Open Data